| Title |
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
|
|---|---|
| Published in |
Trials, July 2020
|
| DOI | 10.1186/s13063-020-04478-w |
| Pubmed ID | |
| Authors |
Xi Liu, Huili Chen, Yuqi Shang, Hongqiong Zhu, Gongqi Chen, Yuanli Chen, Shaoxuan Liu, Yaoyong Zhou, Mingxing Huang, Zhongsi Hong, Jinyu Xia |
Mendeley readers
The data shown below were compiled from readership statistics for 204 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 204 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 35 | 17% |
| Student > Master | 21 | 10% |
| Researcher | 14 | 7% |
| Other | 12 | 6% |
| Student > Ph. D. Student | 12 | 6% |
| Other | 39 | 19% |
| Unknown | 71 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 25% |
| Nursing and Health Professions | 19 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 8% |
| Biochemistry, Genetics and Molecular Biology | 14 | 7% |
| Psychology | 3 | 1% |
| Other | 19 | 9% |
| Unknown | 82 | 40% |